Sona Nanotech Inc (TSE:SONA) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Sona Nanotech Inc. announced promising results from its preclinical study using Targeted Hyperthermia Therapy to treat colorectal cancer, which showed enhanced response rates when combined with standard immunotherapy. The study revealed that tumors in mice were significantly reduced, with half of them eliminated, demonstrating the potential of the therapy to convert resistant cancers into responsive ones.
For further insights into TSE:SONA stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue